Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer
Phase 2
Withdrawn
- Conditions
- Chronic Pain
- Interventions
- First Posted Date
- 2009-07-22
- Last Posted Date
- 2015-09-15
- Lead Sponsor
- Labtec GmbH
- Registration Number
- NCT00943566
News
No news found